The midcap segment of the stock market has been the best performer in recent times, with the BSE midcap index showing a growth of 0.54%. In the last 5 days, this segment has seen a significant increase of 1.31%. This growth has been led by IRFC, with a return of 6.86%, making it the best performer in this segment. On the other hand, Deepak Nitrite has been the worst performer with a return of -4.75%. The advance-decline ratio of stocks in this midcap segment is also positive, with 86 stocks advancing and only 41 declining, resulting in a ratio of 2.1x. This indicates a bullish trend in the market. Investors should keep an eye on the upcoming results of some major companies in this segment. Torrent Pharma, Sun TV Network, Glenmark Pharma, Ashok Leyland, and Aurobindo Pharma are all set to declare their results in the next few days. In terms of stock upgrades, GMR Airports Inf, Colgate-Palmolive, Max Financial, Max Healthcare, and Glaxosmi. Pharma have all been upgraded from mildly bullish to bullish. While Gujarat Gas, Oil India, Deepak Nitrite, LIC Housing Fin., and Torrent Pharma have all been upgraded from hold to buy. On the technical front, the following stocks have seen a change in their technical call in this midcap index: GMR Airports Inf, Colgate-Palmolive, Max Financial, Max Healthcare, and Glaxosmi. Pharma have all been upgraded from mildly bullish to bullish. While Gujarat Gas, Oil India, Deepak Nitrite, LIC Housing Fin., and Torrent Pharma have all been upgraded from hold to buy. Investors should keep a close watch on these stocks and make informed decisions based on the latest market trends and technical calls. With the midcap segment showing strong growth and positive market sentiment, it is a good time for investors to consider investing in this segment.